Tumour size did not show a noticeable influence on the recurrence risk pattern, and this finding was confirmed by the analysis of further subsets of patients (T1 and T2 T3 N-pre-menopausal, T1 and T2 T3 N+ pre-menopausal, T1 and T2 T3 N- post-menopausal, T1 and T2 T3 N+ post-menopausal), in whom tumour size (as well as type of recurrence) failed to change the hazard rate pattern (data not shown).
Although the UICC pTNM classification significantly increased the trend hazard ratio for tumour recurrence, it failed to significantly increase the trend hazard ratio for tumour-related death (Table 6).
The second large RCT of folic acid in CRA recurrence also failed to show an inverse association, but did not provide confirmatory evidence of a positive association (Logan et al, 2008).
The course of MS seems worse than in PM patients, with higher rates of recurrence and 1.5 times more MS experiencing recurrence, although these failed to reach significance.
Although the UICC pTNM classification showed a significant association with tumour recurrence (P=0.018), it failed to show a significant association with tumour-related death (P=0.165).
"Thirty-eight percent of players reported a recurrence of symptoms or failed to match their baseline neurocognitive test during their graduated return to play protocol.
Although ER- and PR-negative tumours tend to be more aggressive, ALDH1 expression did not correlate with recurrence or death, and failed to predict survival, in our study.
Comparison between locoregional recurrence and distant metastasis failed to identify a significant difference for changes in ER, PR, or HER2 (Table 4).
But the uprising alarmed Beijing, which told local officials they would be sacked if they failed to prevent recurrences, according to Chinese journalists briefed on the matter.
Unlike the data presented here with the HSV-2 Δ gD virus, the gH deletion viral vaccine did not prevent the establishment of latency in mice (Speck et al., 1996), was not shown to passively transfer protection and failed to reduce recurrences when evaluated as a therapeutic vaccine in a clinical trial (de Bruyn et al., 2006).
MRI is required to stage local recurrence or in cases where radiography has failed to confirm clinically suspected recurrence.
